
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy has demonstrated positive momentum in its commercial pricing, achieving a sequential increase of 2.2%, with the potential for a 3% rise if not for specific issues in Michigan. Additionally, the company's Industrial Injury Prevention (IIP) revenue exhibited substantial growth of 22.2% overall, and 18.4% when excluding contributions from mergers and acquisitions, indicating strong underlying demand for its services. Furthermore, the recent acquisition of the Metro business has resulted in an increase in the current net rate from approximately $101 to $107.50, reflecting effective integration and value extraction from new assets.
Bears say
US Physical Therapy's stock outlook is negatively impacted by a consistent decline in reimbursement rates, which have led to a $20 million cumulative headwind to profitability over the past five years. Additionally, operating expenses, particularly rent and other costs, have risen to 20.2% of revenue, marginally exceeding initial estimates, which indicates increased operational pressure. Despite a slight increase in other revenue, the ongoing reimbursement cuts and rising costs suggest significant challenges that could affect future profitability and overall financial performance.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares